Human insulin B24 (Phe----Ser). Secretion and metabolic clearance of the abnormal insulin in man and in a dog model.

PubWeight™: 0.84‹?›

🔗 View Article (PMC 425157)

Published in J Clin Invest on May 01, 1984

Authors

S E Shoelson, K S Polonsky, A Zeidler, A H Rubenstein, H S Tager

Articles cited by this

Determination of free and total insulin and C-peptide in insulin-treated diabetics. Diabetes (1977) 2.79

Binding and degradation of 125I-insulin by rat hepatocytes. J Biol Chem (1975) 2.46

Retention and degradation of 125I-insulin by perfused livers from diabetic rats. J Clin Invest (1976) 2.04

A structurally abnormal insulin causing human diabetes. Nature (1979) 1.99

Identification of a mutant human insulin predicted to contain a serine-for-phenylalanine substitution. Proc Natl Acad Sci U S A (1983) 1.67

A human proinsulin variant at arginine 65. Nature (1981) 1.49

Three mutant insulins in man. Nature (1983) 1.40

Metabolism of C-peptide in the dog. In vivo demonstration of the absence of hepatic extraction. J Clin Invest (1983) 1.30

Identification of a point mutation in the human insulin gene giving rise to a structurally abnormal insulin (insulin Chicago). Diabetes (1983) 1.28

Diabetes due to secretion of an abnormal insulin. N Engl J Med (1980) 1.27

Decreased hepatic insulin extraction in subjects with mild glucose intolerance. Metabolism (1983) 1.23

Glucose ingestion in dogs alters the hepatic extraction of insulin. In vivo evidence for a relationship between biologic action and extraction of insulin. J Clin Invest (1982) 1.17

Semisynthesis and biological activity of porcine [LeuB24]insulin and [LeuB25]insulin. Proc Natl Acad Sci U S A (1980) 1.16

Loss of a restriction endonuclease cleavage site in the gene of a structurally abnormal human insulin. Biochem Biophys Res Commun (1981) 1.11

Impaired negative cooperativity of the semisynthetic analogues human [LeuB24]- and [LeuB25]-insulins. Biochem Biophys Res Commun (1981) 1.10

Decreased insulin removal contributes to hyperinsulinemia in obesity. J Clin Endocrinol Metab (1981) 1.08

Studies on mutant human insulin genes: identification and sequence analysis of a gene encoding [SerB24]insulin. Proc Natl Acad Sci U S A (1983) 1.06

Differences in the hepatic and renal extraction of insulin and glucagon in the dog: evidence for saturability of insulin metabolism. Acta Endocrinol (Copenh) (1983) 1.04

[LeuB24]insulin and [AlaB24]insulin: altered structures and cellular processing of B24-substituted insulin analogs. Proc Natl Acad Sci U S A (1982) 1.04

C-Peptide and insulin secretion in Pima Indians and Caucasians: constant fractional hepatic extraction over a wide range of insulin concentrations and in obesity. J Clin Endocrinol Metab (1979) 1.02

Characterization of [LeuB-24]- and [LeuB-25]-insulin analogues. Receptor binding and biological activity. Biochem J (1982) 0.96

Hepatic and renal metabolism of somatostatin-like immunoreactivity. Simultaneous assessment in the dog. J Clin Invest (1981) 0.94

Semisynthesis and biological properties of the [B24-leucine]-, [B25-leucine[- and [B24-leucine, B25-leucine]-analogues of human insulin. Experientia (1981) 0.91

Insulin, C-peptide, and proinsulin in nondiabetics and insulin-treated diabetics. Characterization of the proinsulin in insulin-treated diabetics. Diabetes (1978) 0.79

Articles by these authors

SH2 domains recognize specific phosphopeptide sequences. Cell (1993) 17.28

Backbone dynamics of a free and phosphopeptide-complexed Src homology 2 domain studied by 15N NMR relaxation. Biochemistry (1994) 13.94

Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science (2001) 11.56

Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet (2000) 8.33

Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med (2001) 6.79

Phosphatidylinositol 3'-kinase is activated by association with IRS-1 during insulin stimulation. EMBO J (1992) 5.84

Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: crystal structures of the complexed and peptide-free forms. Cell (1993) 5.47

Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3) Nature (1996) 5.32

Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav. Mol Cell Biol (1994) 5.02

Prevention of fat-induced insulin resistance by salicylate. J Clin Invest (2001) 4.74

Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes (1992) 4.47

Processing mechanisms in the biosynthesis of proteins. Ann N Y Acad Sci (1980) 4.40

Regulation of pancreatic beta-cell growth and survival by the serine/threonine protein kinase Akt1/PKBalpha. Nat Med (2001) 4.07

Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol Cell (1998) 3.84

Diabetes mellitus and genetically programmed defects in beta-cell function. Nature (2001) 3.51

Crystal structure of the tyrosine phosphatase SHP-2. Cell (1998) 3.48

Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1998) 3.41

Proteolytic processing in the biosynthesis of insulin and other proteins. Fed Proc (1974) 3.27

Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck. Nature (1993) 3.14

Oral glucose tolerance test minimal model indexes of beta-cell function and insulin sensitivity. Diabetes (2001) 3.05

Role of apoptosis in failure of beta-cell mass compensation for insulin resistance and beta-cell defects in the male Zucker diabetic fatty rat. Diabetes (1998) 2.94

A cascade of tyrosine autophosphorylation in the beta-subunit activates the phosphotransferase of the insulin receptor. J Biol Chem (1988) 2.90

Determination of free and total insulin and C-peptide in insulin-treated diabetics. Diabetes (1977) 2.79

Hypoglycaemia precipitated by propranolol. Lancet (1966) 2.79

Identification and characterization of a high-affinity interaction between v-Crk and tyrosine-phosphorylated paxillin in CT10-transformed fibroblasts. Mol Cell Biol (1993) 2.47

Roles of circadian rhythmicity and sleep in human glucose regulation. Endocr Rev (1997) 2.39

Characterization of seven C-peptide antisera. Diabetes (1978) 2.29

Increased beta-cell proliferation and reduced mass before diabetes onset in the nonobese diabetic mouse. Diabetes (1999) 2.27

Dileucine-based sorting signals bind to the beta chain of AP-1 at a site distinct and regulated differently from the tyrosine-based motif-binding site. EMBO J (1998) 2.27

United we stand. Ann Intern Med (1993) 2.16

Activation of the SH2-containing phosphotyrosine phosphatase SH-PTP2 by its binding site, phosphotyrosine 1009, on the human platelet-derived growth factor receptor. J Biol Chem (1993) 2.13

C-peptide as a measure of the secretion and hepatic extraction of insulin. Pitfalls and limitations. Diabetes (1984) 2.12

Loss of HNF-1alpha function in mice leads to abnormal expression of genes involved in pancreatic islet development and metabolism. Diabetes (2001) 2.08

Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. Proc Natl Acad Sci U S A (1992) 2.07

Metabolic effects of short-term elevations of plasma cortisol are more pronounced in the evening than in the morning. J Clin Endocrinol Metab (1999) 2.06

Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood. J Clin Invest (1975) 2.04

Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients. J Clin Invest (1986) 2.02

T-cell antigen CD28 interacts with the lipid kinase phosphatidylinositol 3-kinase by a cytoplasmic Tyr(P)-Met-Xaa-Met motif. Proc Natl Acad Sci U S A (1994) 1.95

Structure of the IRS-1 PTB domain bound to the juxtamembrane region of the insulin receptor. Cell (1996) 1.92

The Cbl phosphotyrosine-binding domain selects a D(N/D)XpY motif and binds to the Tyr292 negative regulatory phosphorylation site of ZAP-70. J Biol Chem (1997) 1.87

Evolution of beta-cell dysfunction in the male Zucker diabetic fatty rat. Diabetes (1995) 1.87

Defective insulin secretion in hepatocyte nuclear factor 1alpha-deficient mice. J Clin Invest (1998) 1.86

Proinsulin and the biosynthesis of insulin. Recent Prog Horm Res (1969) 1.78

Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: a meta-analysis. Tissue Antigens (2007) 1.77

SH2 domains exhibit high-affinity binding to tyrosine-phosphorylated peptides yet also exhibit rapid dissociation and exchange. Mol Cell Biol (1993) 1.77

Structure of the regulatory domains of the Src-family tyrosine kinase Lck. Nature (1994) 1.77

Modulation of glucose regulation and insulin secretion by circadian rhythmicity and sleep. J Clin Invest (1991) 1.75

Isolation of a glucagon-containing peptide: primary structure of a possible fragment of proglucagon. Proc Natl Acad Sci U S A (1973) 1.73

Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus. J Clin Invest (1995) 1.70

Receptor binding redefined by a structural switch in a mutant human insulin. Nature (1991) 1.68

Identification of a mutant human insulin predicted to contain a serine-for-phenylalanine substitution. Proc Natl Acad Sci U S A (1983) 1.67

Potent stimulation of SH-PTP2 phosphatase activity by simultaneous occupancy of both SH2 domains. J Biol Chem (1995) 1.66

Spatial constraints on the recognition of phosphoproteins by the tandem SH2 domains of the phosphatase SH-PTP2. Nature (1996) 1.65

Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups. Hum Mol Genet (1997) 1.65

Overexpression of Bcl-x(L) in beta-cells prevents cell death but impairs mitochondrial signal for insulin secretion. Am J Physiol Endocrinol Metab (2000) 1.62

Familial hyperproinsulinemia: partial characterization of circulating proinsulin-like material. Proc Natl Acad Sci U S A (1979) 1.61

Metabolism of proinsulin, insulin, and C-peptide in the rat. J Clin Invest (1973) 1.60

Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on chromosome 12. Diabetes (1996) 1.60

Islet-cell-surface antibodies in juvenile diabetes mellitus. N Engl J Med (1978) 1.59

Normal insulin response to glucose. Lancet (1966) 1.58

Interactions between insulin resistance and insulin secretion in the development of glucose intolerance. J Clin Invest (2000) 1.58

High prevalence of diabetes in young adult Ethiopian immigrants to Israel. Diabetes (1988) 1.56

Circadian modulation of glucose and insulin responses to meals: relationship to cortisol rhythm. Am J Physiol (1992) 1.55

Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome. J Clin Endocrinol Metab (1997) 1.55

CTLA-4 binding to the lipid kinase phosphatidylinositol 3-kinase in T cells. J Exp Med (1995) 1.54

Altered insulin secretory responses to glucose in subjects with a mutation in the MODY1 gene on chromosome 20. Diabetes (1995) 1.54

Crystal structure of human frataxin. J Biol Chem (2000) 1.54

An islet amyloid peptide is derived from an 89-amino acid precursor by proteolytic processing. J Biol Chem (1988) 1.53

Polyoma virus middle T antigen-pp60c-src complex associates with purified phosphatidylinositol 3-kinase in vitro. J Biol Chem (1992) 1.52

Human serum proinsulin. J Clin Invest (1970) 1.52

Proposed changes for NIH's Center for Scientific Review. Panel on Scientific Boundaries for Review. Center for Scientific Review Advisory Committee, National Institutes of Health. Science (1999) 1.52

Giant cell arteritis is more prevalent in urban than in rural populations: results of an epidemiological study of primary systemic vasculitides in Germany. Rheumatology (Oxford) (2000) 1.52

A prospective study of glucose tolerance, insulin, C-peptide, and glucagon responses in patients with pancreatic carcinoma. Am J Dig Dis (1978) 1.51

HLA class II alleles and susceptibility and resistance to insulin dependent diabetes mellitus in Mexican-American families. Nat Genet (1993) 1.50

A human proinsulin variant at arginine 65. Nature (1981) 1.49

Nuclear magnetic resonance structure of an SH2 domain of phospholipase C-gamma 1 complexed with a high affinity binding peptide. Cell (1994) 1.48

Activation of the SH2-containing protein tyrosine phosphatase, SH-PTP2, by phosphotyrosine-containing peptides derived from insulin receptor substrate-1. J Biol Chem (1994) 1.46

Crystal structure of the PI 3-kinase p85 amino-terminal SH2 domain and its phosphopeptide complexes. Nat Struct Biol (1996) 1.46

A bicyclic amino acid to improve discriminations among transport systems. J Biol Chem (1969) 1.45

Tandem SH2 domains confer high specificity in tyrosine kinase signaling. J Biol Chem (1998) 1.45

Haemoglobin A1 and diabetes mellitus. Diabetologia (1978) 1.44

Computer model for mechanisms underlying ultradian oscillations of insulin and glucose. Am J Physiol (1991) 1.43

Syp (SH-PTP2) is a positive mediator of growth factor-stimulated mitogenic signal transduction. J Biol Chem (1994) 1.43

Defects in insulin secretion and action in women with a history of gestational diabetes. Diabetes (1995) 1.43

Crystal structures of peptide complexes of the amino-terminal SH2 domain of the Syp tyrosine phosphatase. Structure (1994) 1.43

Kinetics of human connecting peptide in normal and diabetic subjects. J Clin Invest (1978) 1.42

Evidence for proinsulin in human urine and serum. Lancet (1968) 1.42

Prevention of hyperglycemia in the Zucker diabetic fatty rat by treatment with metformin or troglitazone. Am J Physiol (1996) 1.41

Isolation and characterization of proinsulin C-peptide from bovine pancreas. J Biol Chem (1971) 1.41

A mutant human proinsulin is secreted from islets of Langerhans in increased amounts via an unregulated pathway. Proc Natl Acad Sci U S A (1988) 1.40

Familial hyperproinsulinemia. An autosomal dominant defect. N Engl J Med (1976) 1.40

Brief report: impaired processing of prohormones associated with abnormalities of glucose homeostasis and adrenal function. N Engl J Med (1995) 1.39

Activated mutants of SHP-2 preferentially induce elongation of Xenopus animal caps. Mol Cell Biol (2000) 1.38

The metabolism of proinsulin and insulin by the liver. J Clin Invest (1972) 1.38

Association of IRS-1 with the insulin receptor and the phosphatidylinositol 3'-kinase. Formation of binary and ternary signaling complexes in intact cells. J Biol Chem (1993) 1.38

Phosphatidylinositol 3-kinase p85 SH2 domain specificity defined by direct phosphopeptide/SH2 domain binding. Biochemistry (1993) 1.38

Natural history of intrahepatic canine islet cell autografts. J Clin Invest (1986) 1.37